3,7-dimethyl-1-propargylxanthine has been researched along with pyridoxal phosphate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gabriëls, G; Hohage, H; Hollah, P; Rahn, KH; Schlatter, E; Steinmetz, M; van Le, T | 1 |
| Jankowski, J; Luo, J; Schlüter, H; Schröter, A; Stephan, N; Tepel, M; van der Giet, M; Zidek, W | 1 |
| Erdélyi, F; Sperlágh, B; Szabó, G; Vizi, ES | 1 |
3 other study(ies) available for 3,7-dimethyl-1-propargylxanthine and pyridoxal phosphate
| Article | Year |
|---|---|
Influence of purinoceptor antagonism on diadenosine pentaphosphate-induced hypotension in anesthetized rats.
Topics: Animals; Dinucleoside Phosphates; Hypotension; Male; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Wistar; Receptors, Purinergic P2Y1; Theobromine; Vasodilator Agents; Xanthines | 2000 |
Isolation and characterization of coenzyme A glutathione disulfide as a parathyroid-derived vasoconstrictive factor.
Topics: Acetates; Angiotensin II; Animals; Cell Division; Cells, Cultured; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Coenzyme A; Disulfides; Dose-Response Relationship, Drug; Glutathione; Humans; Mercaptoethanol; Molecular Weight; Muscle, Smooth, Vascular; Parathyroid Glands; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Inbred WKY; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Theobromine; Vasoconstrictor Agents | 2000 |
Local regulation of [(3)H]-noradrenaline release from the isolated guinea-pig right atrium by P(2X)-receptors located on axon terminals.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cadmium; Dose-Response Relationship, Drug; Electric Stimulation; Gene Expression; Guinea Pigs; Heart Atria; Hippocampus; In Vitro Techniques; Male; Norepinephrine; omega-Conotoxin GVIA; Presynaptic Terminals; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; RNA; Superior Cervical Ganglion; Tetrodotoxin; Theobromine; Thionucleotides; Time Factors; Tritium; Xanthines | 2000 |